Table 1. Patient Characteristics Among the GOM Neoadjuvant Cohort (Nā=ā155).
Characteristic | No. (%) |
---|---|
Pathological response in breast and axilla | |
Complete response | 89 (57.4) |
Residual disease | 66 (42.6) |
Hormone receptor status | |
Positive | 105 (67.7) |
Negative | 50 (32.3) |
Intrinsic subtype | |
Luminal A | 38 (24.5) |
Luminal B | 26 (16.8) |
ERBB2 enriched | 80 (51.6) |
Basallike | 8 (5.2) |
Normallike | 3 (1.9) |
Abbreviation: GOM, GOM-HGUGM-2018-05 trial.